GENE ONLINE|News &
Opinion
Blog

Cystic Fibrosis
Pfizer Partners with Renowned Life Sciences VC to Build Pipeline Projected to be Worth $7 Billion
2023-07-20
Vertex’s Orkambi Racks Up Another Approval For Cystic Fibrosis
2022-09-05
Why Cells Move Faster Through Mucus Than Blood
2022-07-28
First Successful Use of Phages for Treating Antibiotic-Resistant Lung Infection
2022-05-16
Tessera Therapeutics Partners with Cystic Fibrosis Foundation to Treat Life-Threatening Disease with Gene Writers
2021-11-05
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
FDA Approves 3 Cystic Fibrosis Drugs of Vertex for Patients with Rare Mutations
2020-12-24
Vertex Bags EU Approval for Cystic Fibrosis Treatment in Children Aged 6-11 Years
2020-11-29
Ionis’ Inhaled Antisense Medicine Could Signal Decline for Cystic Fibrosis Medical Devices
2020-10-15
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
An Outlook on the Evolution of Cystic Fibrosis Care
2020-05-13
LATEST
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Thailand’s Largest Biotech Event Takes Center Stage
2023-09-22
BIOHK2023: A place where biotechnology meets financial economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
Dreams and Nightmares: the Mysterious Activities of the Brain During Deep Sleep
2023-09-20
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top